1 – 20 of 26
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Morbiditet från urinvägar och tarm enligt registerdata efter ultrahypofraktionerad strålbehandling för lokaliserad prostatacancer vid 10 år i HYPO-RT-PC-studien
2024) Onkologidagarna 2024(
- Contribution to conference › Poster
-
Mark
Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
(
- Contribution to conference › Abstract
-
Mark
Register data on long-term morbidity after prostate cancer radiotherapy with ultra-hypofractionated (2.5 weeks) vs conventional (8 weeks) treatment schedules
2024) U21 Health Sciences Group 2024 Doctoral Student Forum(
- Contribution to conference › Poster
- 2023
-
Mark
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
(
- Contribution to journal › Article
- 2022
-
Mark
Paediatric diagnostic reference levels for common radiological examinations using the European guidelines
(
- Contribution to journal › Article
- 2021
-
Mark
Establishing paediatric diagnostic reference levels using reference curves - A feasibility study including conventional and CT examinations
(
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
- 2020
-
Mark
Radical radiotherapy for prostate cancer : patterns of care in Sweden 1998–2016
(
- Contribution to journal › Article
-
Mark
Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer : A Population-Based Cohort Study
(
- Contribution to journal › Article
- 2019
-
Mark
Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients
(
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer : 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
- 2018
-
Mark
Prostate Cancer Death After Radiotherapy or Radical Prostatectomy : A Nationwide Population-based Observational Study
(
- Contribution to journal › Article
-
Mark
Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer a secondary analysis of a randomized clinical trial
(
- Contribution to journal › Article
- 2017
-
Mark
Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
(
- Contribution to journal › Article
- 2016
-
Mark
Long-term adverse effects after curative radiotherapy and radical prostatectomy : population-based nationwide register study
(
- Contribution to journal › Article
-
Mark
Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer : A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice
(
- Contribution to journal › Article
-
Mark
The Proteome of Primary Prostate Cancer.
(
- Contribution to journal › Article
- 2015
-
Mark
Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancer
(
- Contribution to journal › Article